OrbiMed, BlueRun, Sofinnova lead late-decade venture portfolio at CalSTRSByMark Boslet21 December 2017•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FeaturedFundraisingInvestorsManagersFeaturedFundraisingInvestor PerformancePensionsPerformance
